News & Resources

4 Tips for Managing Content That Will Improve Pharma Marketing Strategies

In a saturated market full of messaging about improved drugs, how do you reach your audience? Of course, it’s all about quality content, but to improve your marketing reach, you also need to use the mechanisms of community to amplify your message. This means understanding the advantages of different messaging mediums and fitting each with highly appropriate and engaging content.

This requires a lot of content and a way to manage it all. One approach to organizing all this content is to design a comprehensive company website with multiple sub-sites. This platform supports a variety of content that can reach a range of different audiences, all while maintaining consistent messaging. A content-management system (CMS) can help focus content in a time-challenged environment, implement changes across the board, audit the effectiveness of a campaign, and above all, allow marketers to control the message.

1. Multiple Websites
Online marketing is more effective than TV and print in reaching and maintaining target audiences; to be competitive today, it is not uncommon for pharma companies to have more than a single website. In fact, they might introduce up to a dozen separate sites or sub-sites: one for each product, specific conditions or symptoms, or resources deemed valuable for healthcare professionals and consumers.

Another reason for developing multiple sites is that most website audiences are self-selective—websites should be designed with the primary intent to pull in audience interaction. A pharma website should foremost be viewed as a resource that offers value to its audience; each site should focus on a targeted message that answers the needs of its recipients.

A site for patients might feature health libraries, patient resources, news, online games, and polls and have the capability to customize content. For healthcare professionals, information on products, clinical trial data, research, ordering, and online seminars should be available. Multiple websites are a good way to parcel information and focus on a targeted audience with targeted messaging. Of course, multiple websites mean an abundance of additional content to manage.

2. Content-Management Systems
Content-management requirements extend across multiple sites as well as all other mediums of communication (social media platforms, industry journals, billboards), and each medium needs to be consistent with the next. This vigorous task is often handled by a CMS, which supports consistent messaging and reliable distribution of information. With an ability to update and audit content across platforms, these systems further help to keep information current and complete.

Besides allowing administrators to control messaging inside and outside the company, a CMS supports additional channels that fulfill corporate and commercial requirements: media kits and press releases, business model descriptions, financial news, investor presentations, and investor kits. A strong CMS even provides templates for creating new content, controlling consistency and brand messaging.

Where online content-management tools are being used to help manage press rooms, FAQ pages, sub-sites, and online publications, they have also demonstrated effectiveness in building communities for reinforcing product opinions and establishing brand loyalty. A CMS with built-in auditing controls allows administrators to track changes as well as identify audience interaction, ensuring that content is consistent as well as engaging.

3. Timelines
Content management gives organizations control over the information and messaging shared both inside and outside the company. Traditionally, timing is a huge challenge in the pharma environment—whether it’s racing to introduce a new product to market, discovering a new indication of an old compound, or riding on fast-paced industry trends.

When it comes to managing content, processes must be in place to define when and how to publish content. A CMS typically allows you to schedule the distribution of information, be it an email, a press release, or a published study, or for the systematic mounting of a general marketing campaign.

There is no doubt that creating content-management timelines and scheduling CMS-controlled distribution is a beneficial practice. In a more literal take on timelines, marketers should appeal to social content calendars for awareness days or incorporate interactive calendars as a website feature. For example, a company making pharmaceutical products targeting women’s health created an interactive due-date calendar that helped women track pregnancy milestones online.

4. Content Variety
These days, you need to consider communications that entirely fill the information space surrounding your product or brand, not just the individual customer. Which sites do your customers visit? Which journals do they read? Which pharmacies or resources do they like to consult? Hitting the different channels and content types not only helps you better engage your target, but it also helps build a solid community that can reinforce the opinions surrounding your products or company.

Offering a range of content is necessary for maintaining brand identity and controlling message consistency. You should definitely consider what content you publish on which channels, but having a large arsenal of content available makes management practices ultimately more effective. You should have ready media kits, press releases, general corporate information, financial news, investor presentations, investor kits, FAQs, outcomes data, product information, and resources for patients and healthcare providers.

Online collaboration is another valuable (and engaging) source for content variety, in which the contributors’ goal is to increase the group’s collective knowledge while supporting the brand message and product education. Collaboration encourages the participation of both internal and external constituents and includes online user groups, clinical specialty groups, patient/physician care groups, sales force communities, and partner networks.

Therapeutic Area

Archives

Matthew Gordon

VP, Real-World Evidence
Matthew has more than 25 years of experience in real-world evidence and observational, non-interventional research. He has led studies across the full life cycle—from startup through publication—supporting objectives that range from understanding a disease’s natural history to fulfilling global safety surveillance requirements. Matthew brings deep expertise in orphan disease programs, having overseen more than 25 long-term, global initiatives, as well as in disease and product registries, prospective pharmacoeconomic studies, and systematic literature reviews. Matthew leads the RWE Registries team, responsible for building the business and team. Prior to joining Aptitude Health, he held senior leadership roles at Parexel, Worldwide Clinical Trials, inVentiv Health Clinical, Quintiles Outcome, and ICON Clinical Research. Matthew holds a BA in sociology from Boston University, is a long-standing member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and is a frequent speaker at ISPOR, the Center for Business Intelligence, and related industry conferences.

Gerald Stanvitch, PhD

VP, Scientific Content

Cate Browning, PhD

VP, Global Medical Affairs

Erin Zingales Rau

VP, Account Services

Kelly Kocor

VP, People & Culture
Kelly leads both the human resources and talent acquisition teams, ensuring that Aptitude Health attracts, retains, and develops top personnel to drive our continued success. With over 17 years of experience transforming global HR initiatives, Kelly is an expert in harmonizing HR policies and fostering a culture of engagement and partnership. She is committed to partnering with all areas of the business to ensure full regulatory compliance and delivering value-added services to our organization and its people. Kelly is passionate about developing and implementing HR strategies that help support our employees’ professional and personal growth. She is dedicated to fostering a culture that encourages innovation, collaboration, and inclusivity, helping Aptitude Health continue to be a great place to work.

Bart Zygmond

VP, Finance
Bart brings a wealth of experience to the organization, having worked in the life sciences, pharmaceuticals, manufacturing, and service industries. With his expertise in financial reporting, US GAAP, SOX, cash flow modeling, and financial analysis, he plays a crucial role in the company’s financial management and strategy. Prior to joining Aptitude Health as VP, Finance, Bart held several controller positions: at Q2 Solutions, he oversaw the global finance team and financial operations, ensuring the accurate and timely financial reporting of the company. He also held controller positions at Domtar Inc and Veristat.

Eugene Vissers, MD

Senior VP, Global Scientific Content
Eugene is a seasoned medical doctor with over 20 years of international experience in pharma, consultancy, and agency environments. Eugene leads the US team of dedicated experts responsible for developing high-quality medical content. Prior to joining Aptitude Health, Eugene served as medical director at Ipsen and AstraZeneca. With both his medical degree and an MBA, Eugene brings a unique perspective to his role. His clinical background, combined with his business acumen, allows him to develop innovative strategies that drive results. Under Eugene’s leadership, the medical content team delivers scientific information of the highest quality, providing valuable insights to our clients around the world.

Adrian Barfield

VP, US Business Development

Kelley Hernandez

Executive VP, US Business Development
Kelley has over 18 years of experience in the oncology space. Kelley joined Aptitude Health after working with Cardinal Health, where she was part of the Healthcare and Analytics Division, and finished her tenure there with VitalSource™ (GPO division). As the leader of the strategic business development team for the US, Kelley brings a wealth of expertise to the organization. Her experience in the healthcare industry, combined with her ability to identify and capitalize on new business opportunities, is invaluable in driving the company’s growth and success. Kelley’s dedication to building strong relationships with life science partners is a testament to her commitment to delivering exceptional value to the healthcare industry.

Adam Sinensky, MBA

Chief Technology Officer

Adam has over 20 years of experience in the healthcare industry and an MBA in healthcare management. After 10 years as a strategy consultant to life science companies, Adam has spent the last decade as a product and strategy leader focused on bringing technology products to market across the payor, provider, and life sciences segments. By combining his business acumen and experience working directly with software developers, engineers, and data scientists, Adam has successfully led numerous product launches and enhancements from ideation to development and go-to-market initiatives. His product and change management expertise has led organizational shifts from services to technology at companies such as Change Healthcare and Datavant/Ciox. At Aptitude Health, Adam is responsible for growing our portfolio of product offerings by leveraging real-world data and artificial intelligence with our existing solutions and industry-leading Axess Network of healthcare providers. He also oversees our IT and cybersecurity teams.

Stefanie Daniels

Chief Commercial Officer

Stefanie is a seasoned healthcare executive with over 20 years of experience in oncology. She brings a wealth of knowledge and expertise to the organization. Stefanie joined Aptitude Health after spending over a decade as a senior director at Physicians’ Education Resource, an oncology CME vendor. During her tenure, she led and managed teams responsible for grant development/acquisition, program creation/execution, and faculty management. Stefanie’s deep understanding of the oncology industry and her ability to lead teams through complex projects make her a vital part of the organization’s success. Her dedication to providing high-quality solutions to our life science partners is a testament to her commitment to improving cancer patient care.

Jason Cash

Chief Financial Officer

Jason is an accomplished finance professional with over 20 years of experience in the pharmaceutical services industry. Throughout his career, he has demonstrated a keen ability to navigate high-growth organizations, delivering exceptional results. Before joining Aptitude Health, Jason served as the CFO of Veristat International, a global contract research organization. In this role, he led the financial strategy and played a pivotal role in driving the company’s growth and success. Jason’s wealth of experience and expertise in financial management make him an essential member of the leadership team. His strategic thinking and ability to drive results are highly respected within the industry.

Jez Moulding

Chief Executive Officer
Jez is a seasoned leader with over 20 years of experience in general management and regional president roles. He has a proven track record of success in the healthcare industry, having worked in the US, Japan, Australia, Korea, South Africa, France, and the UK for Sanofi, where he supported the launch of 10 new drugs across various therapeutic areas. As chief commercial officer at UDG Healthcare and EVP at Ashfield, Jez demonstrated his expertise in developing and implementing successful business strategies. He joined Aptitude Health from Pharmaspectra, an IQVIA business, where he served as CEO since 2018. Jez’s extensive experience in the pharmaceutical industry and his leadership skills make him an invaluable asset to the organization.